U.S. Markets closed
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • Dow 30

    34,935.47
    -149.06 (-0.42%)
     
  • Nasdaq

    14,672.68
    -105.59 (-0.71%)
     
  • Russell 2000

    2,226.25
    -13.78 (-0.62%)
     
  • Crude Oil

    73.81
    +0.19 (+0.26%)
     
  • Gold

    1,812.50
    -18.70 (-1.02%)
     
  • Silver

    25.55
    -0.23 (-0.90%)
     
  • EUR/USD

    1.1871
    -0.0025 (-0.2137%)
     
  • 10-Yr Bond

    1.2390
    -0.0300 (-2.36%)
     
  • Vix

    18.24
    +0.54 (+3.05%)
     
  • GBP/USD

    1.3906
    -0.0051 (-0.3685%)
     
  • USD/JPY

    109.6150
    +0.1540 (+0.1407%)
     
  • BTC-USD

    41,732.40
    +1,742.18 (+4.36%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

BEMER Group & Centropix Resolve Dispute

·2 min read

SAN DIEGO, July 22, 2021 /CNW/ -- BEMER USA, LLC is pleased to announce that it has successfully resolved its dispute with its former distributors, George Gasich and Youcef Benloucif and their new venture Centropix USA, LLC. In April 2021, BEMER filed a lawsuit against Gasich, Benloucif and Centropix after becoming aware that they were engaging in unlawful cross-recruitment and competition. In the lawsuit, BEMER quickly secured a temporary restraining order from the Court, preventing the former distributors Gasich and Benloucif from breaching their non-compete and non-solicitation agreements. Pursuant to the settlement, the Court has entered a permanent federal injunction, restraining Gasich, Benloucif, and Centropix from recruiting and/or enrolling current, and certain former, BEMER distributors until April 22, 2022. The injunction also limits the products that Centropix can market in the United States and the statements that Centropix can make in marketing its products.

BEMER USA, LLC has successfully resolved its lawsuit dispute with its former distributors new venture Centropix.

The result marks an important achievement in protecting BEMER's confidential information and the businesses of BEMER's independent distributors. BEMER is committed now and in the future to continue to take all necessary steps to protect its and its distributors' business.

Contact compliance@bemer.services for any questions regarding this lawsuit or the outcome.

About BEMER:
BEMER® USA, LLC is a subsidiary of BEMER International AG, a leading global medical device company specializing in the research and development of microcirculation products. Founded in 1998, BEMER now operates in over 42 countries, with hundreds of employees and thousands of independent distributors. BEMER is a leading innovator in physical vascular therapy technology and holds FDA and Health Canada registrations along with numerous technology patents. BEMER PEMF therapy products have been shown to increase blood circulation, which can enhance Cardiac Function, Muscle Stimulation, Muscle Recovery, Physical Fitness/Endurance, Stress Reduction, Relaxation and Sleep Quality. BEMER products are currently used globally by millions of consumers, hospitals and clinics, hundreds of professional athletes, as well as for horse therapy. To learn more, please visit https://life.bemergroup.com/

SOURCE BEMER USA, LLC

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/July2021/22/c7226.html